Home / Drugs / peginterferon beta-1a

peginterferon beta-1a

FDA Drug Profile — Plegridy, Plegridy Pen

Drug Details

Generic Name
peginterferon beta-1a
Brand Names
Plegridy, Plegridy Pen
Application Number
BLA125499
Sponsor
Biogen Inc.
NDC Codes
6
Dosage Forms
LIQUID, INJECTION, SOLUTION, KIT
Routes
INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredients
PEGINTERFERON BETA-1A

Indications and Usage

1 INDICATIONS AND USAGE PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 )